optimised production of 64cu sartate for a phase 1 clinical trial charmaine jeffery, clarity pharmac
Published 7 years ago • 243 plays • Length 12:58Download video MP4
Download video MP3
Similar videos
-
2:28
clinical trial: cam2029 for neuroendocrine tumors (nct05050942)
-
13:20
neuroendocrine cancer clinical trials & research: the importance of the patient's perspective
-
9:38
understanding neuroendocrine cancer research
-
9:42
68ga 64cu labelling and affinity study of nodaganoc a nodaga conjugated somatostatin analogue rana b
-
6:38
clinical trials: neuroendocrine tumors
-
4:36
neuroendocrine tumours (nets) video series: nutrition
-
7:44
imaging of neuroendocrine tumors with edward wolin, md
-
5:25
explaining neuroendocrine tumours (nets) and our latest clinical trial
-
16:05
current clinical trials
-
7:00
treating metastases associated with neuroendocrine tumors (nets)
-
27:54
treatments across the neuroendocrine cancer spectrum
-
13:37
clinical trials 101
-
14:38
debate: is there a role for surgical management of metastatic neuroendocrine cancer? - yes
-
22:44
first-line therapy for advanced neuroendocrine tumors (nets) — simron singh, md, mph
-
5:24
neuroendocrine tumor guidelines
-
9:20
neuroendocrine tumor diagnosis in children, teens, & young adults with m. sue o'dorisio, md
-
1:37
clinical trial approved for new cancer treatment
-
1:15:11
advances in net treatment